An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckM. Degardin, P Cappelaere, J Chauvergne et al.|Annals of Oncology|1998Cited by 38
Sustained Tumor Control With MAPK Inhibition in <i>BRAF</i> V600–Mutant Adult Glial and Glioneuronal TumorsGiulia Berzero, Anna Luisa Di Stefano, Luisa Bellu et al.|Neurology|2021Cited by 30
Phase II study of vlnorelbine in patients with hormone refractory prostate cancerArmelle Caty, Dominique Chopin, Stéphane Oudard et al.|European Journal of Cancer|1997Cited by 6